I thought they would have done this type of study early in the process...apparently not. I always wondered what the fate of the spike protein was after manufacture by our cells...apparently it gets around. interesting that 11 out of 13 got s1 protein. That’s 85% response. Lower than 99% efficacy rating....
Big problem is as I see it is that any cell which gets the mrna in it can make spike protein and those cells can be targeted by immune system and killed...having a universal carrier like the mrna vaccine doesnt necessarily distinguish what cells it goes into....
Verdict: EXPERIMENTAL VACCINE. Much to be learned. Should only be given to volunteers. NEVER MANDATED till fully tested and cleared for human use(with option to REFUSE)
P.S. Very small study. Did they include all 80 million gender identification categories?
All text above is IMHO.
This was the very problem brought up by Robert Malone on the DarkHorse podcast about a month ago. The vaccine transports the mRNA by encasing it in a lipid nanoparticle. Lipids, or fats, are designed to "stick" to the body's cell surface and facilitate entry of the nRNA, which then instructs the ribosomes to construct spike proteins. The body then mounts an immune response defense and ultimately the host cells are killed, because the body considers them "infected". The issue, as noted by Dr. Malone is that it has been shown the lipid nanoparticles don't stay near the injection site, as intended. They enter the bloodstream and migrate throughout the body. They unfortunately have a special affinity for winding up in bone marrow and in woman's ovaries, as well as the lungs, the heart, etc. Now, instead of muscle cells being killed, where muscle cells can be readily restored, you have the body's own immune response attacking vital organs like bone marrow or ovaries. Probably not a good thing.